Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
Toulemonde, E., Chevret, S., Battistella, M., Neidhardt, E. M., Nardin, C., Le Du, F., Meyer, N., Véron, M., Gambotti, L., Lamrani-Ghaouti, A., Jamme, P., Chaffaut, C., De Pontville, M., Saada-Bouzid, E., Beylot-Barry, M., Simon, C., Jouary, T., Marabelle, A., Mortier, L.
Published in Cancer Immunology, Immunotherapy (01.08.2023)
Published in Cancer Immunology, Immunotherapy (01.08.2023)
Get full text
Journal Article
Clinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations
JAMME, P., Escande, F., Descarpentries, C., Copin, M.C., Dansin, E., Vanparis, T., Tulasne, D., Baldacci, S., Kherrouche, Z., Cortot, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
362P Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)
Bossi, P., Minuti, G., Braña, I., Moreno Garcia, V., Boni, V., Jamme, P., Call, J.A., Yan, C., Barasa, B., Doze, P., Joe, A.K., Laus, G., Daste, A.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
467 (PB455): IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER +/HER2- metastatic breast cancer
Cosci, C., Jamme, P., Kumar, V., Nadler, M.B., Rayson, D., Melvin, J., Rushton, M., Awan, A., Levasseur, N., Chia, S., Bedard, P., Hilton, J., Finn, S., Tu, W., Antrás, J.F., Unger, T.J., Cescon, D., Seymour, L., Pearce, L.
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
516MO Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, combined with osimertinib, as first-line therapy or after progression on osimertinib in non-small cell lung cancer (NSCLC)
Cappuzzo, F., Moreno Garcia, V., Ou, S-H.I., Brandão, M., Sanmamed, M.F., Helissey, C., Wislez, M., Call, J.A., Grisanti, S., Johnson, M.L., Boni, V., Jamme, P., Monnet, I., Siena, S., Yan, C., Barasa, B., Richard, B., Joe, A.K., Laus, G., Felip, E.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
1258P MET exon14 skipping in non-small cell lung cancer: Clinicopathological characteristics, treatments, and efficacy of crizotinib according to functional analysis: AFonMET - GFPC study
Babey, H., Jamme, P., Gervais, R., Assié, J-B., Veillon, R., Doubre, H., Pérol, M., Guisier, F., Huchot, E., Decroisette, C., Falchero, L., Chiappa, A-M., André, M., Cortot, A.B., Chouaid, C., Le Gac, G., Descourt, R.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1493PClinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations
JAMME, P, Escande, F, Descarpentries, C, Copin, M C, Dansin, E, Vanparis, T, Tulasne, D, Baldacci, S, Kherrouche, Z, Cortot, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study
Baldacci, S., Figeac, M., Antoine, M., Descarpentries, C., Kherrouche, Z., Jamme, P., Copin, M., Tulasne, D., Nanni, I., Beau-Faller, M., Melaabi, S., Levallet, G., Quoix, E., Moro-Sibilot, D., Friard, S., Missy, P., Barlesi, F., Cadranel, J., Cortot, A.B.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
MA 07.06 Detection of Mechanisms of Resistance to ALK Inhibitors in Routine Practice: A Retrospective Study
Jamme, P., Descarpentries, C., Wislez, M., Dansin, E., Grégoire, V., Baldacci, S., Escande, F., Mathiot, N., Kyheng, M., Kherrouche, Z., Copin, M.C., Cortot, A.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
Traitement des patients atteints d’un mélanome métastatique cérébral par ipilimumab à haute dose et radiochirurgie : résultats à 5 ans
Macaire, C., Jamme, P., Henri, M., Robert, C., Lesimple, T., Thomas, L., Machet, L., Philippe, S., Lebbe, C., Dutriaux, C., Grob, J.-J., Duhamel, A., Labreuche, J., Desmedt, E., Templier, C., Mirabel, X., Reyns, N., Le Rhun, E., Mortier, L.
Published in Annales de dermatologie et de vénéréologie (01.12.2020)
Published in Annales de dermatologie et de vénéréologie (01.12.2020)
Get full text
Journal Article
Ipilimumab combiné à une radiochirurgie-stéréotaxique chez des patients porteurs d’un mélanome avec métastases cérébrales. Une étude de phase 2, multicentrique, ouverte
Mortier, L., Jamme, P., Lacour, J.-P., Robert, C., Lesimple, T., Thomas, L., Machet, L., Saiag, P., Lebbe, C., Dutriaux, C., Grob, J.J., Duhamel, A., Desmedt, E., Templier, C., Mirabel, X., Reyns, N., Le Rhun, E.
Published in Annales de dermatologie et de vénéréologie (01.12.2018)
Published in Annales de dermatologie et de vénéréologie (01.12.2018)
Get full text
Journal Article